Stephen Sukumar Nuthalapati

Stephen Sukumar Nuthalapati

Auto-generated profile, based on publicly available information

Stephen Sukumar Nuthalapati

Viral Gene Expression Group, The Pirbright Institute, Guildford, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
VGVictoria Gonzalez
Victoria Gonzalez
BLBriallen Lobb
Briallen Lobb
JCJacob Côté
Jacob Côté
ABArkadeb Bhuinya
Arkadeb Bhuinya
ATAdriana G. Tubb
Adriana G. Tubb
ABArinjay Banerjee
Arinjay Banerjee
Bats are reservoirs of emerging zoonotic viruses that may cause severe disease in humans and agricultural animals. However, it is poorly understood how bats can tolerate diverse viral infections. Here, we characterized type I interferon response pathways in kidney cell lines derived from two divergent bat species, Pteropus alecto and Eptesicus fuscus, identifying distinct mechanisms underlying their enhanced control of viral infection. We demonstrate the critical roles of STAT1/STAT2 in IFNβ signaling, along with species-specific adaptations that contribute towards a steady and ready antiviral state. Unlike in humans, bat IFNβ signaling processes resist the immune antagonistic properties of MERS-CoV which further explains the ability of bats to tolerate coronavirus infections. Transcriptomic analysis on interferon stimulated cell lines identified canonical and non-canonical interferon stimulated genes including two differentially expressed genes, IFIT1 and GBP1, that exhibit enhanced antiviral activity against a wide range of viruses, including the bat-derived Eptesipoxvirus. We have identified a functional (AV1) motif within E. fuscus GBP1 that restricts Eptesipoxvirus replication. Ultimately, our work provides important insights into the evolution of enhanced interferon-mediated antiviral responses in bats, contributing to their ability to resist viral diseases.

4 October 2025 in bioRxiv
Verified
Preprint
Open access
MVMiguel Aracena Velazquez
Miguel Aracena Velazquez
SNStephen Sukumar Nuthalapati
Stephen Sukumar Nuthalapati
JHJacqueline Hankinson
Jacqueline Hankinson
KFKsenia Fominykh
Ksenia Fominykh
VLValeria Lulla
Valeria Lulla
CHChris H. Hill
Chris H. Hill
Enteroviruses are a widespread and diverse set of pathogens responsible for over ∼1 billion human infections annually. Upon cell entry, translation of the virus genome is mediated by an internal ribosome entry site (IRES) in the 5’ untranslated region (UTR). Despite early identification of the poliovirus IRES, structure determination has been hampered by the flexibility and complexity of the RNA (∼450 nt, five structured domains), the requirement for almost all of the eukaryotic initiation factors (eIFs), and additional dependency on PCBP2 for trans-activation. As a result, there is little mechanistic information on how enterovirus Type 1 IRESs recruit and direct translational machinery. To address this, here we reconstitute human translation initiation on a model poliovirus IRES and examine 48S complexes by electron cryo-microscopy (cryo-EM). Our structures reveal a novel set of interactions between the IRES and the translation machinery. Domain IVc contacts uS19 and uS13 on the small ribosomal subunit, and the conserved apical GNRA tetraloop interacts directly with the initiator tRNA during start-codon recognition. We demonstrate that disruption of these contacts causes defects in IRES-driven translation and virus replication. Together, our results define the structural and molecular basis for translation initiation on the Type 1 IRES, and highlight the potential for RNA-RNA tertiary interactions as new targets for antiviral therapeutics.

26 November 2024 in Research Square
Verified
Preprint
Open access
PDF file
ABArinjay Banerjee
Arinjay Banerjee
VGVictoria Gonzalez
Victoria Gonzalez
BLBriallen Lobb
Briallen Lobb
JCJacob Cote
Jacob Cote
ABArkadeb Bhuinya
Arkadeb Bhuinya
ADAndrew Doxey
Andrew Doxey
Bats are reservoirs of emerging zoonotic viruses of concern that cause severe disease in humans and agricultural animals. However, it is poorly understood how bats are able to tolerate diverse viral infections, knowledge that could help pave the way for new therapeutic strategies. Here, we characterized antiviral pathways in two divergent bat species, Pteropus alecto and Eptesicus fuscus, identifying unique bat-specific mechanisms underlying their enhanced antiviral tolerance. We demonstrate the critical roles of STAT1 and STAT2 in IFNβ signaling, along with species-specific adaptations that collectively contribute towards a “steady and ready” antiviral state in bat cells. Unlike in humans, we find that bat interferon signalling processes resist the immune antagonistic properties of viruses like MERS-CoV which further explains the ability of bats to tolerate coronavirus infections. Using transcriptomic analysis, we identified canonical and non-canonical interferon stimulated genes (ISGs) including two key bat genes, IFIT1 and GBP1. Compared to their human orthologs, we show that bat IFIT1 and GBP1 exhibit enhanced antiviral activity against a wide range of RNA and DNA viruses, including coronaviruses and additional bat-derived poxviruses (e.g., Eptesipoxvirus). Ultimately, our work provides important insights into the evolution of enhanced interferon-mediated antiviral responses in bats, contributing to their unique ability to resist viral diseases.